Appellate

Appellate Law360 provides breaking news and analysis on appellate law. Coverage includes major cases in the federal courts of appeal, the U.S. Supreme Court, and state-level appeals courts, with a focus on petitions, briefs, oral arguments, decisions, and other major activity.



Sign up for a 7-day FREE trial today!



Latest News in Appellate

  • August 19, 2026

    5th Circ. Tells FDA To 'Rethink' Rule Behind E-Cig Rejection

    The Fifth Circuit on Wednesday agreed with vaping companies that the U.S. Food and Drug Administration overstepped its authority when it repeatedly blocked approval of flavored e-cigarettes without a notice-and-comment period, holding that the repeated denials constitute a rule that the agency must "rethink" or readopt properly.

  • August 19, 2026

    Amazon Wants Full 9th Circ. To Rethink Block On Perplexity AI

    Amazon is pressing the full Ninth Circuit to consider a lower court's injunction preventing Perplexity's "uniquely reckless" artificial intelligence tool from purchasing items for users on Amazon, arguing that a panel erred in lifting the block earlier this month.

  • August 19, 2026

    German Entrepreneur's Dad Can't Nix SEC Tab, 1st Circ. Rules

    The First Circuit on Wednesday affirmed a judgment against the father of German billionaire Michael Gastauer, saying the parent "waited too long" to object to a lower court's personal jurisdiction over him as a relief defendant in a case concerning his son's alleged participation in an international pump-and-dump scheme.

  • August 19, 2026

    2nd Circ. Revives Signature Bank Investor Suit Against Execs

    The Second Circuit on Wednesday revived a shareholder lawsuit over alleged misstatements about Signature Bank's health ahead of its 2023 collapse, finding that a New York federal court was wrong to toss the case because securities fraud claims against the defunct bank do not transfer to the Federal Deposit Insurance Corp. as the banks' receiver.

  • August 19, 2026

    Abbott Deal Ends Appeal After $495M Baby Formula Trial Loss

    Abbott Laboratories Inc. has struck a deal with a family that won a $495 million judgment against the U.S. pharmaceutical company in a bellwether trial over claims that its baby formula caused a premature baby to suffer a disabling condition, after a midlevel appellate court upheld the win, according to court filings.

See more Appellate news

Appellate

Areas of Coverage

  • LITIGATION
  • Petitions and notices of appeal in federal and state appeals courts
  • Appellant and opposition briefs
  • Solicitor general briefs
  • Oral arguments in appellate cases
  • Opinions handed down by appellate judges and panels
  • Bankruptcy appeals
  • POLICY & REGULATION
  • Federal and state regulation and legislation that affects appellate procedure
  • Legislative responses to or attempts to overturn appeals court decisions
  • PROFILES
  • Nominations and appointments of appellate judges and justices
  • Personnel moves

Readership

  • Appellate lawyers at top law firms
  • Judges and court staff across the U.S.
  • Policymakers at federal and state agencies
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals